Corrigendum to 'National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016' Heart Lung and Circulation volume 25, (2016) 898 - 952
1 Flinders University and Regional Director of Cardiology, Department of Cardiovascular Medicine, Southern Adelaide Health Service, SA, Australia.
2 Internal Medicine and Clinical Epidemiology, Princess Alexandra Hospital, Brisbane, Qld, Australia; School of Medicine, University of Queensland, Brisbane, Qld, Australia; Medicine, Monash University, Melbourne, Vic, Australia.
3 Department of Emergency Medicine, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia.
4 Director of Coronary Care and Director of Cardiovascular Research, Liverpool Hospital, Sydney, NSW, Australia.
5 Cardiovascular Research Group, School of Population Health, University of Western Australia, Perth, WA, Australia.
6 Integrated Cardiovascular Clinical Network (iCCnet), Country Health SA Local Health Network and Southern Adelaide Local Health Network, Adelaide, SA, Australia.
9 Senior Policy Advisor, National Heart Foundation of Australia.
10 Network Director, Division of Medicine, Cardiac and Critical Care, Southern Adelaide Local health Network, Flinders Medical Centre and University, SAHMRI, Adelaide, SA, Australia.
Please note that on p.929 in 5.2.2.7, paragraph 3, the dose of dabigatran should read as BD rather than daily. We regret any inconvenience that this may have caused.